Velcade (Bortezomib for Injection) Observational Study

Trial Profile

Velcade (Bortezomib for Injection) Observational Study

Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2014

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Xian-Janssen
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 03 Oct 2012 Primary endpoints added as reported by
    • 05 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top